Jim Tananbaum a Healthcare Entrepreneur and Investor

Dr. Molly, a former senior director at Illumina, joined Foresight Capital as a venture partner. Molly has vast experience in pharmaceuticals, genomic research, and development that spans to over a decade. Molly has specialized in the area of next generation sequencing. In a statement on SpeakerPedia, Jim Tananbaum the CEO and managing director of Foresight Capital said that Dr. Molly would be an invaluable asset to Foresight as he brings with her extensive expertise in the field of genomics and drug development. In addition, Dr. Molly has a remarkable track record in leadership.

Before joining Illumina, Dr. Molly worked with Pacific Bio-sciences where he was the head of protein science and was responsible for protein reagent development. Dr. Molly for ten years worked in the pharmaceutical industry and focused on designing antibodies and small molecule drugs that targeted cancer and immune diseases.

Dr. Molly has a rich academic background. He is an alumni of the University of Nankai where he pursued a degree course in the field of biochemistry . Molly later advanced his education and attended the University of California where he was awarded a PhD in Protein Biophysics. Dr. Molly in his long list of achievements is also an author and Patent holder.

Dr. Molly in a statement said he was honored to Join Foresight and together with the Seasoned and dynamic team of Foresight, he would help the company grow the next generation sequencing portfolio a field that is potential for creating breakthroughs in clinical research and drug discovery.

Foresight Capital is located in San Francisco and has an office also in New York.The company is popularly known for providing healthcare growth capital to its long list of clients.

Dr. Jim Tananbaum is the Founder and Chief executive officer of Foresight Capital Management. Dr. Jim Tananbaum has a lot of experience in the healthcare sector and has successfully led over 21 investments in the healthcare industry. Some of the investments James has led are Amira Pharmaceuticals, Amerigroup, and Jazz Pharmaceuticals.

Dr. Tananbaum an alumnus of the Ivy League universities holds an M.D. from Harvard school of medicine, and an M.B.A from Harvard business school. Besides, James holds a B.S and B.S.E.E from Yale University.

Leave a Reply

Your email address will not be published. Required fields are marked *